0 results available. Select is focused ,type to refine list, press Down to open the menu,
KYORIN Pharmaceutical Co., Ltd., through its subsidiaries, researches and develops, manufactures, and sells ethical and generic drugs in Japan and internationally. The company offers Flutiform, a drug...
The following section summarizes insights on Kyorin Holdings Inc's Price Close (Div & Split Adjusted):
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Price Close (Div & Split Adjusted) in the valuation category include:
The price at the close of the last trading day. Price history is adjusted for stock splits and dividends, as applicable.
The chart above depicts the distribution of price close (div & split adjusted) for companies operating in the Healthcare sector in the Developed economic region. Over 3,140 companies were considered in this analysis, and 3,085 had meaningful values. The average price close (div & split adjusted) of companies in the sector is 1,273 with a standard deviation of 3,313.
Kyorin Holdings Inc's Price Close (Div & Split Adjusted) of 1,558 ranks in the 82.2% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 3,147 |
| Included Constituents | 3,085 |
| Min | 0.00015 |
| Max | 26,972 |
| Median | 129.98 |
| Mean | 1,273 |
| Standard Deviation | 3,313 |
You can find companies with similar price close (div & split adjusted) using this stock screener.